Dabrafenib Mesylate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
Determining the interaction of Dabrafenib Mesylate and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Nuwiq recombinant
- Dabrafenib Mesylate-NuZole
- Dabrafenib Mesylate-Nuzyra
- Dabrafenib Mesylate-Nuzyra (Omadacycline Injection)
- Dabrafenib Mesylate-Nuzyra (Omadacycline Tablets)
- Dabrafenib Mesylate-Nuzyra Intravenous
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dacarbazine
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Dacarbazine Intravenous, Injection
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Daclatasvir
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Daclatasvir Dihydrochloride
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Daclizumab
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Daclizumab Subcutaneous